Fact CheckerSign in

NCT06497842Completed

Effort During Resistance Training in Type 2 Diabetes

The Effect of Perceived Effort in Resistance Training on Glycemic Control and Psychological Responses in Individuals Living With Type 2 Diabetes Mellitus: a Randomized-controlled, Parallel Group, Clinical Trial

Source: ClinicalTrials.gov · Last updated 3 Sept 2026

Brief summary (registry, in English)

In this study the primary aims are to investigate the effect of resistance exercise training with different degrees of effort on glycemic control and psychological variables in individuals living with type 2 diabetes mellitus. As a secondary aim, investigate adherence and dropout rates and reasons for dropping out and adhering or not to the protocols.

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
28 Jun 2024
Start date
10 Sept 2024
Primary completion date
5 Mar 2026
Lead sponsor
University of New Mexico
NCT number
NCT06497842

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 10 Sept 2024 to the primary completion date, 5 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have a significant cognitive impairment,
  • Have renal failure,
  • Have liver disease,
  • Have uncontrolled hypertension (\>160 mmHg systolic and/or \>100 mmHg diastolic),
  • Have unstable cardiovascular disease,
  • Have a history of severe cardiovascular problems,
  • Have decompensated heart failure,
  • Have uncontrolled arrhythmias,
  • Have severe pulmonary hypertension (mean pulmonary arterial pressure \>55 mm Hg),
  • Have Marfan syndrome,
  • Have rapidly progressive terminal illness,
  • Are unable to perform resistance exercise to due preexisting musculoskeletal conditions (e.g., joint pain, chronic injury or tendinopathy),
  • Have taken drugs known to increase the risk of tendon disorders (e.g., tendinopathy and tendon rupture) within the last 6 months. These drugs include, but may not be limited to: fluoroquinolones, glucocorticoids, aromatase inhibitors, anabolic steroids, antiretrovirals, isotretinoin, cephalexin, rituximab, sitagliptin, cephalosporins, azithromycin, and sulfonamides.
  • Have acute illness,

Other

  • Are non-ambulatory,
  • Have lower extremity amputation,
  • Have severe and symptomatic aortic stenosis,
  • Have acute myocarditis, endocarditis, or pericarditis,
  • Have aortic dissection,
  • Have unrepaired aortic aneurysm,
  • Have proliferative diabetic retinopathy,
  • Are under biguanide (metformin) treatment, but are taking for less than 3 months,
  • Are pregnant or trying to become pregnant during the study,
  • Are prisoners,
  • Are persons that require a legally authorized representative.
    • Temporary exclusions include:
  • Being subjected to recent surgeries for which resistance training is not recommended,
  • Have symptomatic hernias,
  • Have recent fractures, or other injuries until resolved.

Who the study is looking for

  • Living with type 2 diabetes mellitus

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UNM Exercise Physiology Lab
Coordinator of this site? Confirm its status
AlbuquerqueUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.